April 2nd, 2020 – BitCare specializes in the personalization of health and wellness through its genomic testing services. BitCare’s partner lab is a CDC designated SARS-CoV-2 (COVID-19) testing facility. Through that partnership, BitCare is offering the tests at “no profit to the company for healthcare entities who are in dire need,” says Ric S Kolluri, CEO of BitCare. Also, he added, “we have reached out and started to work with local and state-level officials to offer our services to help flatten the curve.”
Dr. Jason Finkelstein, BitCare’s Board of Advisor, and who is on the front line of this coronavirus pandemic, said, “this pandemic is a once in a generation event that modern medicine has not seen in over a hundred years. As a community, and better yet as a nation, we need to follow the CDC guidelines to flatten the curve. Please stay home, keep social distancing, and check in on your loved ones. We will get through this. We have the greatest healthcare in the world, and the healthcare providers are putting their lives first every single day to protect you and the public.”
It has become imperative to increase the number of approved testing centers and help identify and minimize the spread of the virus. While there has been widespread awareness of COVID-19, there is a shortage of testing kits and longer turnaround time. Although BitCare is relatively a young company it has quickly managed to be part of the solution to address the global health crisis of COVID-19 testing shortage. BitCare has one of the most robust platforms and made arrangements to speed up the testing process to have the results in 24-48 hours after receiving the sample; currently, it’s averaging about 1-2 weeks for the test results to come back from other laboratories.
The company is joining its forces with healthcare providers to help fight the lack of access to testing to minimize the spread of COVID-19. “We have already started working with providers to get the test results back in 24-48 hours; their biggest pain point right now is the turnaround time,” says Jags Porandla, COO of BitCare.
“Currently, our test kits are intended for the evaluation of respiratory symptoms consistent with COVID-19 as outlined by the CDC. Now, We have a virus without a treatment protocol, and no vaccine at this time. We at BitCare continue our research with our partner labs to develop new testing methods and evaluating several drugs to mitigate the novel SARS-CoV-2,” says Dr. Siva Yadavalli, the Chief Scientist of BitCare.
BitCare Technologies, Inc. is a Dallas based Biotech startup offering AI-based precision health and wellness services through at-home DNA & Allergy testing. DNA products offer personalized insights based on a person’s DNA on Health, Diet, Exercise, Sport, Estrogen, Addiction, Behavior, and also provides some advanced DNA tests in Parkinson’s, Alzheimer’s, ALS, and Dementia. All tests are simple to use at-home tests with a simple 20-second cheek swab; with free shipping. Also, BitCare offers Allergy, Intolerance, and Sensitivity testing, which analyzes up to 800 food and non-food items. All the tests are accessible through a secure BitCare’s platform.
For more information about BitCare, visit https://www.bitcare.co.